Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
07/1998
07/21/1998US5783518 Dye diffusion thermal transfer printing
07/16/1998WO1998030569A1 Asymmetric synthesis and catalysis with chiral heterocyclic compounds
07/16/1998WO1998030541A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion
07/16/1998WO1998030539A1 Novel thiocarbamic acid derivatives
07/16/1998WO1997048672A3 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
07/16/1998CA2277105A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion
07/15/1998EP0719263B1 Heterocyclic carboxamide derivatives with antiarrhythmic activity
07/15/1998CN1187808A Optically active substituted pheynylalkylamine derivatives
07/14/1998US5780676 Bicyclic benzyl, pyridinyl, thiophene, furanyl, pyrrole, and polyenoic acid derivatives
07/14/1998US5780648 Benzothiophene compounds, and uses formulations thereof
07/14/1998US5780647 2,4-Pentadienoic acid derivatives having retinoid-like biological activity
07/14/1998US5780640 Process for the biotechnological preparation of L-thienylalanines in enantiomerically pure form from 2-hydroxy-3-thienylacrylic acids and their use
07/14/1998US5780512 Alkylated (hetero) cyclic compounds
07/14/1998US5780483 IL-8 receptor antagonists
07/14/1998US5780480 Thrombolytic agents, anticoagulants
07/14/1998US5780470 Melatonergic indanyl piperazines
07/14/1998CA2041113C Thienobenzodiazepine derivatives and their use as pharmaceuticals
07/09/1998WO1998029877A1 Proton conductor in liquid form
07/09/1998WO1998029399A1 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
07/09/1998WO1998029396A1 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
07/09/1998WO1998029389A1 Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/09/1998WO1998029388A1 Perfluorinated amide salts and their uses as ionic conducting materials
07/09/1998WO1998029387A1 Aminobutyric acid fungicides
07/09/1998WO1998029384A1 Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect
07/09/1998WO1998029383A1 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect
07/09/1998WO1998029358A2 Surface modified carbonate materials
07/09/1998DE19700097A1 3-Aminocarbonyl/3-Aminothiocarbonyl-substituierte 2-Benzoyl-cyclohexan-1,3-dione 3-Aminocarbonyl / 3-aminothiocarbonyl-substituted 2-benzoyl-cyclohexane-1,3-diones
07/09/1998DE19700019A1 Substituierte 2-Benzoyl-cyclohexan-1,3-dione Substituted 2-benzoyl-cyclohexane-1,3-diones
07/09/1998CA2805188A1 Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye
07/09/1998CA2704986A1 Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye
07/09/1998CA2683826A1 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
07/09/1998CA2277014A1 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect
07/09/1998CA2276584A1 Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect
07/08/1998EP0852137A2 Cosmetic compositions containing a photostable UV-A filter
07/08/1998EP0851850A1 SYNTHESIS OF $g(a)-CHLORO OR FLUORO KETONES
07/08/1998EP0750611B1 Anilide derivatives as fungicides
07/08/1998CN1187183A Process for hydrogenation of imines
07/07/1998US5777150 Substituted amic acid derivatives
07/07/1998US5777089 Nonlinear optical device, colored textile, printing ink
07/07/1998US5776984 Prostaglandin synthase-2 inhibitors
07/07/1998US5776983 Antidiabetic agents, obesity, gastrointestinal disorders
07/07/1998US5776982 Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals
07/07/1998US5776981 Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals
07/07/1998US5776977 Arylcycloalkyl derivatives, their production and their use
07/07/1998US5776974 Immunosuppressant compounds
07/07/1998US5776933 Method of inhibiting protease
07/07/1998US5776859 Sodium channel active novel compounds and related processes and bioassay techniques
07/07/1998US5776699 Method of identifying negative hormone and/or antagonist activities
07/02/1998WO1998028284A1 Process for the preparation of heteroaryl-phenylalanines
07/02/1998WO1998028282A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
07/02/1998WO1998028275A1 Novel compounds with analgesic effect
07/02/1998WO1998028265A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
07/02/1998WO1998028264A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
07/02/1998DE19757627A1 Azulenderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzung, die diese Verbindungen enthält Azulene derivatives, processes for their preparation and pharmaceutical composition containing these compounds
07/02/1998CA2276034A1 Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors
07/02/1998CA2275665A1 Nitromethylthiobenzene derivatives as aldose reductase inhibitors
07/01/1998EP0850933A1 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials
07/01/1998EP0850932A1 Salts of heterocyclic anions and their uses as ionic conductive materials
07/01/1998EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents
07/01/1998EP0850921A1 Salts of malononitrile derived anions, and their uses as ionic conductive materials
07/01/1998EP0850920A2 Salts of perfluorinated amides and their uses as ionic conductive materials
07/01/1998EP0850232A1 Benzothiazolone derivatives
07/01/1998EP0850221A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/01/1998CN1186434A Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
06/1998
06/30/1998US5773594 Treating skin disorders, reducing side effects of other retinoids
06/30/1998US5773465 Tartronic acids, their acetalic ethers and o-esters
06/30/1998US5773459 Enzyme inhibitors of kinases and anticarcinogenic agents
06/25/1998WO1998027081A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
06/25/1998WO1998027058A2 N-piperazin-1-ylphenyl-benzamide derivatives
06/25/1998WO1998027053A1 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
06/25/1998WO1998026773A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
06/25/1998CA2275492A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
06/25/1998CA2274055A1 N-piperazin-1-ylphenyl-benzamide derivatives
06/25/1998CA2264692A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
06/24/1998EP0848957A1 Fas LIGAND SOLUBILIZATION INHIBITOR
06/24/1998EP0848706A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists
06/24/1998EP0848703A1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii
06/24/1998EP0848701A1 O-benzyl oxime ether derivatives and their use in crop protection compositions
06/24/1998EP0848700A1 Acylaminosalicylic acid amides and their uses as pesticides
06/24/1998EP0848698A1 Fluorobutene acid amides
06/24/1998EP0848697A1 Process for the hydrogenation of imines
06/24/1998EP0848696A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
06/24/1998CN1185435A Sulfamide-substituted compound, preparation method, and medicinal preparation containing same
06/24/1998CN1038835C Isoparaffin-olefin alkylation
06/23/1998US5770612 Administering substituted benzothiophenes, solvates or salts along with analgesics, diuratics or antihistaminesalong with
06/23/1998US5770453 Measuring any electrical properties change after or during exposuring a sample to a calixarenes
06/18/1998WO1998025919A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
06/18/1998WO1998025918A1 Analgesic, anti-inflammatory and anti-thrombosis esters of nitrated cycloaliphatic alcohols
06/18/1998WO1998025915A1 Fused heterocyclic benzenecarboxylic acid amide derivatives and pgd2 antagonists containing the same
06/18/1998WO1998025893A1 Arylsulfonamides as phospholipase a2 inhibitors
06/18/1998WO1998025883A1 Ketobenzamides as calpain inhibitors
06/18/1998WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
06/18/1998WO1998025616A1 Leukotriene antagonists for cerebral focal stroke
06/18/1998WO1998025601A1 Fibrinogen receptor antagonists
06/18/1998WO1998025597A2 Method for treating and preventing heart failure and ventricular dilatation
06/18/1998WO1998016522A3 Aminophenol derivates with fungicidal property
06/18/1998CA2274908A1 Leukotriene antagonists for cerebral focal stroke
06/18/1998CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
06/18/1998CA2274029A1 Fibrinogen receptor antagonists
06/18/1998CA2263886A1 Method for treating and preventing heart failure and ventricular dilatation